11/14/2024
2:24 PM | ARMISTICE CAPITAL, LLC (Filed by)
Brainstorm Cell Therapeutics (Subject)
| Form SC 13G | |
11/13/2024
6:55 AM | Brainstorm Cell Therapeutics (Subject)
Ruck Matthew J (Filed by)
| Form SC 13G | |
10/30/2024
7:41 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
7:00 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
7:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2024
11:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form EFFECT | |
09/26/2024
3:30 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
09/24/2024
3:30 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3/A | |
09/17/2024
2:32 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/16/2024
3:36 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2024
11:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form EFFECT | |
08/28/2024
4:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
08/16/2024
6:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form DEF 14A | |
08/16/2024
6:03 AM | Brainstorm Cell Therapeutics (Filer)
| Form ARS | |
08/14/2024
7:01 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/14/2024
6:15 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/31/2024
3:08 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024
3:09 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024
3:05 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024
3:06 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024
3:06 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024
3:07 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/31/2024
3:07 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4/A | |
07/24/2024
3:05 PM | Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/19/2024
3:05 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2024
9:49 AM | Brainstorm Cell Therapeutics (Filer)
| Form 424B5 | |
06/28/2024
6:30 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
8:00 AM | Brainstorm Cell Therapeutics (Filer)
| Form 424B5 | |
06/26/2024
3:01 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
8:03 PM | Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
06/25/2024
8:04 PM | Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
4:24 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
5:05 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/03/2024
8:00 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/23/2024
5:00 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2024
6:53 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
6:41 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
8:14 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
3:06 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/25/2024
3:01 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
7:06 PM | Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad) The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget!
We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] |
04/19/2024
5:05 AM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
8:31 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
5:10 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/09/2024
5:05 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/02/2024
3:15 PM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/01/2024
8:16 AM | Brainstorm Cell Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
04/01/2024
7:15 AM | Brainstorm Cell Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
7:54 PM | Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
7:55 PM | Brainstorm Cell Therapeutics (Issuer)
Patlis Alla (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
7:56 PM | Brainstorm Cell Therapeutics (Issuer)
Yablonka Uri (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
7:57 PM | Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
9:06 AM | Brainstorm Cell Therapeutics (Subject)
Ness Kevin Dean (Filed by)
| Form SC 13G/A | |
